O'Connor Daniel J.

CEO at Ambrx Biopharma, Inc.; CEO and President at ONCOSEC MEDICAL Inc; Chief Executive Officer at Advaxis, Inc.

Sold, on record
$998k
Dollars the filings state
Form 4 sales
13
Latest Oct 27, 2023
Form 144 notices
1
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ONCOSEC MEDICAL IncPlan not stated
    Jan 31, 2020 2020

    Sold 2,654 shares at $1.96 ($5k)

    O'Connor Daniel J., CEO and President

    Sold 3.9% of holdings ($135k position)66,061 shares leftFiling

  2. 2 Form 4 sale ONCOSEC MEDICAL IncPlan not stated
    Apr 30, 2020 +90 days

    Sold 3,075 shares at $1.79 ($6k)

    O'Connor Daniel J., CEO and President

    Sold 4.7% of holdings ($118k position)62,986 shares leftFiling

  3. 3 Form 4 sale ONCOSEC MEDICAL IncPlan not stated
    Jul 31, 2020 +92 days

    Sold 3,133 shares at $4.20 ($13k)

    O'Connor Daniel J., CEO and President

    Sold 2.9% of holdings ($458k position)105,962 shares left1.2x usual sizeFiling

  4. 4 Form 4 sale ONCOSEC MEDICAL IncPlan not stated
    Nov 2, 2020 +94 days

    Sold 3,280 shares at $3.79 ($12k)

    O'Connor Daniel J., CEO and President

    Sold 3.1% of holdings ($402k position)102,682 shares left1.1x usual sizeFiling

  5. 5 Form 4 sale ONCOSEC MEDICAL IncPlan not stated
    Feb 1, 2021 +91 days

    Sold 3,413 shares at $7.71 ($26k)

    O'Connor Daniel J., CEO and President

    Sold 3.3% of holdings ($792k position)99,269 shares left1.1x usual sizeFiling

  6. 6 Form 4 sale ONCOSEC MEDICAL IncPlan not stated
    Apr 30, 2021 +88 days

    Sold 3,172 shares at $4.86 ($15k)

    O'Connor Daniel J., CEO and President

    Sold 3.2% of holdings ($482k position)96,097 shares left1x usual sizeFiling

  7. 7 Form 4 sale Ambrx Biopharma, Inc.Routine
    Oct 27, 2023 +910 days

    Sold 50,012 shares at $9.82 ($491k)

    O'Connor Daniel J., President and CEO

    10b5-1 planSold 12.7% of holdings ($3.9M position)342,845 shares leftFirst sale on recordFiling

  8. 8 Form 144 notice Ambrx Biopharma, Inc.Notice
    Nov 1, 2023 +5 days

    Filed to sell 50,012 shares ($491k)

    O'Connor Daniel J., CEO

    No 10b5-1 planFiling

Every transaction

Loading transactions…

Sales and notices (14)

Form 144 notices and Form 4 sales by O'Connor Daniel J.
Source
Nov 1, 2023Nov 1, 2023Ambrx Biopharma, Inc.CEOForm 144 notice50,012$491kNoticeSEC
Oct 27, 2023Oct 31, 2023Ambrx Biopharma, Inc.President and CEOForm 4 sale50,012$491k12.7%RoutineSEC
Apr 30, 2021May 4, 2021ONCOSEC MEDICAL IncCEO and PresidentForm 4 sale3,172$15k3.2%Plan not statedSEC
Feb 1, 2021Feb 2, 2021ONCOSEC MEDICAL IncCEO and PresidentForm 4 sale3,413$26k3.3%Plan not statedSEC
Nov 2, 2020Nov 3, 2020ONCOSEC MEDICAL IncCEO and PresidentForm 4 sale3,280$12k3.1%Plan not statedSEC
Jul 31, 2020Aug 4, 2020ONCOSEC MEDICAL IncCEO and PresidentForm 4 sale3,133$13k2.9%Plan not statedSEC
Apr 30, 2020May 4, 2020ONCOSEC MEDICAL IncCEO and PresidentForm 4 sale3,075$6k4.7%Plan not statedSEC
Jan 31, 2020Feb 3, 2020ONCOSEC MEDICAL IncCEO and PresidentForm 4 sale2,654$5k3.9%Plan not statedSEC
Oct 31, 2019Nov 1, 2019ONCOSEC MEDICAL IncCEO and PresidentForm 4 sale2,128$5k3.0%Plan not statedSEC
Nov 2, 2016Nov 2, 2016Advaxis, Inc.Chief Executive OfficerForm 4 sale8,240$69k2.7%Plan not statedSEC
May 2, 2016May 2, 2016Advaxis, Inc.Chief Executive OfficerForm 4 sale8,237$62k2.6%Plan not statedSEC
Jan 29, 2016Feb 1, 2016Advaxis, Inc.Chief Executive OfficerForm 4 sale8,818$61k2.7%Plan not statedSEC
Oct 30, 2015Nov 3, 2015Advaxis, Inc.Chief Executive OfficerForm 4 sale8,350$102k2.5%Plan not statedSEC
Jul 31, 2015Aug 4, 2015Advaxis, Inc.Chief Executive OfficerForm 4 sale8,449$130k2.4%Plan not statedSEC